Trial intelligence / Profile preview

DWJ211 in Moderate or Severe Submental Fat

NCT03224117Phase 2Completed

Sponsor
Daewoong Pharmaceutical
Start
Oct 2017
Primary completion
Jun 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of sodium deoxycholate in submental fat, sponsored by Daewoong Pharmaceutical. Started Oct 2017; status: completed.

02

Drugs

sodium deoxycholate
03

Conditions

submental fat

Beyond the preview

Go deeper on NCT03224117.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03224117.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call